fluocinolone acetonide implant Yutiq
Selected indexed studies
- Preliminary evaluation of YUTIQ™ (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis. (Ther Deliv, 2019) [PMID:31663454]
- Efficacy of the Fluocinolone Acetonide (Yutiq) Intravitreal Implant as Monotherapy for Uveitis. (Ocul Immunol Inflamm, 2023) [PMID:35793136]
- Yutiq - another fluocinolone intravitreal implant for uveitis. (Med Lett Drugs Ther, 2021) [PMID:34544110]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review. (2019) pubmed
- Preliminary evaluation of YUTIQ™ (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis. (2019) pubmed
- Fluocinolone acetonide implant (Iluvien®) for macular edema associated with retinitis pigmentosa: A case report. (2023) pubmed
- Yutiq - another fluocinolone intravitreal implant for uveitis. (2021) pubmed
- Efficacy of the Fluocinolone Acetonide (Yutiq) Intravitreal Implant as Monotherapy for Uveitis. (2023) pubmed
- INTRAVITREAL FLUOCINOLONE ACETONIDE IMPLANT FOR RADIATION RETINOPATHY: Report of Preliminary Findings. (2023) pubmed
- Radiation-induced maculopathy and fluocinolone acetonide implant. (2025) pubmed
- Fluocinolone Acetonide Implant Removal From the Vitreous Cavity. (2023) pubmed
- Fluocinolone acetonide implant in diabetic macular edema: International experts' panel consensus guidelines and treatment algorithm. (2022) pubmed
- INTRAVITREAL 0.18-mg FLUOCINOLONE ACETONIDE IMPLANT FOR PEDIATRIC UVEITIS. (2024) pubmed